See also this year's filing and all EDGAR filings for this company.
PDF Report 0001488613_2014_Foundation_Medicine_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Foundation Healthcare Inc', 'shared_tokens': {'foundation'}}]} |
| warning | No stock price available | subcommand.plot | {} |
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'RestrictedCashAndCashEquivalentsNoncurrent', 'OtherAssetsNoncurrent', 'CashAndCashEquivalentsAtCarryingValue', 'AccountsReceivableNetCurrent', 'InventoryNet', 'PrepaidExpenseAndOtherAssetsCurrent', 'AccountsPayableCurrent', 'LiabilitiesCurrent', 'AccruedLiabilitiesCurrent', 'DeferredRevenueCurrent', 'DeferredRentCreditCurrent', 'NotesPayableCurrent', 'PreferredStockValue', 'StockholdersEquity', 'CommonStockValue', 'AdditionalPaidInCapital', 'RetainedEarningsAccumulatedDeficit'))"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001488613')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001488613, Foundation Medicine Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 129,000 |
| 2 | AssetsCurrent | 133,310,000 |
| 3 | PropertyPlantAndEquipment | 22,104,000 |
| 4 | remainder_Assets | 1,725,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 15,759,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 11,659,000 |
| 10 | GeneralAndAdministrativeExpense | 21,865,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 12,326,000 |
| 15 | ResearchAndDevelopmentExpense | 24,901,000 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 28,990,000 |
| 18 | remainder_NetIncome | -1,183,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 157,268,000 |
| 1 | Liabilities | 15,759,000 |
| 2 | Expenses | 70,751,000 |
| 3 | Revenues | 28,990,000 |
| 4 | StockholdersEquity | 141,509,000 |
| 5 | NetIncome | -42,944,000 |
| 6 | ComprehensiveNetIncome | -42,944,000 |
| 7 | BaseVar | 136,975,500 |
| 8 | EconomicCapitalRatio | 4.05 |